FIELD: biochemistry.
SUBSTANCE: invention relates to novel organosilicon monofunctional disubstituted benzothienobiotiophene derivatives, method of their production and their use in electronics. Compound of the general formula (I), where R1 denotes C2-C13 alkyl, R denotes C3-C18 alkenyl, X denotes O or halogen, and y is 1 or 2, that when y is 1, X is halogen, and in the case where y is 2, X is O. Invention also relates to process for preparation of compound (I), semiconductor layer and an electronic device containing the compound (I), and using the compound (I). .
EFFECT: technical result: proposed compound allows to obtain a semiconductor layer on various substrates, suitable for obtaining flexible, thermally stable and stable electronic devices of large area.
21 cl, 9 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
CONDENSED THIOPHENE DERIVATIVE, BENZOTHIOPHENE DERIVATIVE, THIENOBENZOXAZEPINONE DERIVATIVE, PHARMACEUTICAL AGENT AND PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2197491C2 |
PYRROLOPYRIMIDINE COMPOUNDS FOR MALIGNANT TUMOUR TREATMENT | 2012 |
|
RU2631655C2 |
ACTIVATING AGENT FOR RECEPTOR ACTIVATED BY PEROXISOME GROWTH-STIMULATING AGENTS | 2009 |
|
RU2501794C2 |
BENZOTHIOPHENES AND RELATED COMPOUNDS AS STING AGONISTS | 2019 |
|
RU2806274C2 |
DERIVATIVES OF TETRAHYDROISOQUINOLINE, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD FOR INHIBITION OF SYNAPTIC UPTAKE OF DOPAMINE AND TREATMENT METHOD | 2000 |
|
RU2293728C2 |
DERIVATIVES OF HETEROARENE CARBOXAMIDE, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND USING | 2003 |
|
RU2320656C2 |
METHOD OF SYNTHESIS OF IMIDAZOLE DERIVATIVES | 1997 |
|
RU2188821C2 |
PYRIMIDINE DERIVATIVES AS INHIBITORS OF PD1/PD-L1 ACTIVATION | 2018 |
|
RU2783211C2 |
METHOD OF PRODUCING 2,3-DISUBSTITUTED INDOLES | 2006 |
|
RU2466126C2 |
AGONISTS OF PROTEIN TYROSINE PHOSPHATASE-1 CONTAINING HOMOLOGY-2 SRC DOMAIN, AND METHODS OF TREATING USING SAID AGONISTS | 2012 |
|
RU2584986C2 |
Authors
Dates
2019-05-07—Published
2014-10-21—Filed